Similar articles

• Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.

  Rutanen EM, Seppälä M. Rutanen EM, et al. J Clin Endocrinol Metab. 1980 Jan;50(1):57-61. doi: 10.1210/jcem-50-1-57. J Clin Endocrinol Metab. 1980. PMID: 6243133 No abstract available.
• Biochemical markers in gynaecological cancer.

  Farrell RJ. Farrell RJ. Ir Med J. 1980 Aug;73(8):285-6. Ir Med J. 1980. PMID: 6161106 No abstract available.
• Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.

  Lee JN, Salem HT, Chard T, Huang SC, Ouyang PC. Lee JN, et al. Br J Obstet Gynaecol. 1982 Jan;89(1):69-72. doi: 10.1111/j.1471-0528.1982.tb04639.x. Br J Obstet Gynaecol. 1982. PMID: 6277363
• Pregnancy-specific beta 1-glycoprotein in complicated early pregnancy and trophoblastic disease.

  Seppälä M, Rutanen EM, Stenman UH, Siiteri JE. Seppälä M, et al. Ric Clin Lab. 1982 Jan-Mar;12(1):251-4. doi: 10.1007/BF02909332. Ric Clin Lab. 1982. PMID: 6283617 Review. No abstract available.
• [Role of biochemical tumor markers in the diagnosis and monitoring of neoplastic processes].

  Szymendera J. Szymendera J. Nowotwory. 1982 Jan-Jun;32(1-2):7-17. Nowotwory. 1982. PMID: 6184677 Review. Polish. No abstract available.